Pierre Fabre Laboratories has received a positive opinion from the [...]

People with extensive-stage small cell lung cancer in England and [...]

Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

Patients across South Florida are set to gain greater access [...]

Countable Labs has raised $26 million in an oversubscribed financing [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

Protara Therapeutics has reported updated 12-month data from its ongoing [...]

Veristat has launched an AI-enabled biostatistics platform designed to reduce [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]

Grow Therapy has published its first peer-reviewed outcomes study, reporting [...]